Literature DB >> 1928047

Prognostic indicators in compensated cirrhosis.

M Zoli1, M R Cordiani, G Marchesini, T Iervese, A M Labate, C Bonazzi, G Bianchi, E Pisi.   

Abstract

In an attempt to identify variables predicting prognosis, 100 consecutive patients with compensated cirrhosis of the liver were followed for a mean of 4.9 (SD 0.7) yr. Fifty-one patients belonged to Child-Pugh class A, 49 to class B. At entry, five laboratory parameters were considered, together with sex, the grade of esophageal varices, and seven variables measured by ultrasonography (liver and spleen volume and the calibers of the splanchnic vessels). In a subgroup of 56 patients, the galactose elimination capacity also was determined. Forty-six patients were alive at the end of follow-up. Survival was analyzed according to Cox's model. Six parameters were able to predict survival (albumin, bilirubin, liver volume, prothrombin activity, cholesterol, varices). However, step-wise Cox regression analysis identified only four variables that independently correlated with survival: albumin, bilirubin, cholesterol, and liver volume. Galactose elimination failed to add any significance to routine liver function tests. This prospective study confirms the ability of routine liver function tests in predicting survival in compensated cirrhosis. The measurement of liver volume, easily obtained by ultrasonography, is also significant for prognosis, and may be introduced into clinical practice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928047

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  Measurement of liver volume and its clinical significance in cirrhotic portal hypertensive patients.

Authors:  Ji-Ye Zhu; Xi-Sheng Leng; Nan Dong; Gui-Ying Qi; Ru-Yu Du
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  Automated segmentation and quantification of liver and spleen from CT images using normalized probabilistic atlases and enhancement estimation.

Authors:  Marius George Linguraru; Jesse K Sandberg; Zhixi Li; Furhawn Shah; Ronald M Summers
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

3.  High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis.

Authors:  Kazuhiro Kotoh; Makoto Nakamuta; Marie Fukushima; Chitose Matsuzaki; Munechika Enjoji; Hironori Sakai; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

4.  A simple method for accurate liver volume estimation by use of curve-fitting: a pilot study.

Authors:  Masahito Aoyama; Yoshiharu Nakayama; Kazuo Awai; Yukihiro Inomata; Yasuyuki Yamashita
Journal:  Radiol Phys Technol       Date:  2012-11-11

Review 5.  Non-invasive diagnosis of alcoholic liver disease.

Authors:  Sebastian Mueller; Helmut Karl Seitz; Vanessa Rausch
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

6.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

7.  Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease.

Authors:  Eduardo Vilar Gomez; Luis Calzadilla Bertot; Bienvenido Gra Oramas; Enrique Arus Soler; Raimundo Llanio Navarro; Javier Diaz Elias; Oscar Villa Jiménez; Maria del Rosario Abreu Vazquez
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

8.  Assessing hepatomegaly: automated volumetric analysis of the liver.

Authors:  Marius George Linguraru; Jesse K Sandberg; Elizabeth C Jones; Nicholas Petrick; Ronald M Summers
Journal:  Acad Radiol       Date:  2012-02-22       Impact factor: 3.173

9.  The effects of bile duct obstruction on liver volume: an experimental study.

Authors:  Bahtiyar Ertor; Serdar Topaloglu; Adnan Calik; Umit Cobanoglu; Ali Ahmetoglu; Huseyin Ak; Erdem Karabulut; Mithat Kerim Arslan
Journal:  ISRN Surg       Date:  2013-06-05

10.  Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.

Authors:  Robert P Myers; Abdel Aziz M Shaheen; Peter Faris; Alexander I Aspinall; Kelly W Burak
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.